{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:41:23Z","timestamp":1789828883048,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001323","name":"Poliomyelitis Research Foundation","doi-asserted-by":"crossref","award":["12\/10"],"award-info":[{"award-number":["12\/10"]}],"id":[{"id":"10.13039\/501100001323","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","award":["UID 85544"],"award-info":[{"award-number":["UID 85544"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12985-015-0392-3","type":"journal-article","created":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T20:15:10Z","timestamp":1444076110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease"],"prefix":"10.1186","volume":"12","author":[{"given":"Petrus","family":"Jansen van Vuren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Shalekoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette A.","family":"Grobbelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett N.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juno","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline T.","family":"Tiemessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz T.","family":"Paweska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"key":"392_CR1","first-page":"1037","volume-title":"Infectious Diseases of Livestock","author":"R Swanepoel","year":"2004","unstructured":"Swanepoel R, Coetzer JA. Rift Valley fever. In: Coetzer JA, Tustin RC, editors. Infectious Diseases of Livestock. Cape Town: Oxford University Press Southern Africa; 2004. p. 1037\u201370."},{"key":"392_CR2","first-page":"972","volume":"18","author":"C C\u00eatre-Sossah","year":"2012","unstructured":"C\u00eatre-Sossah C, P\u00e9darrieu A, Guis H, Deferenz C, Bouloy M, Favre J, et al. Prevalence of Rift Valley fever among ruminants, Mayotte. Emerg Infect Dis. 2012;18:972\u20135.","journal-title":"Emerg Infect Dis"},{"key":"392_CR3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1017\/S0950268807009806","volume":"136","author":"A Evans","year":"2008","unstructured":"Evans A, Gakuya F, Paweska JT, Rostal M, Akoolo L, Jansen Van Vuren P, et al. Prevalence of antibodies against Rift Valley Fever virus in Kenyan wildlife. Epidemiol Infect. 2008;136:1261\u20139.","journal-title":"Epidemiol Infect"},{"key":"392_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3201\/eid0802.010023","volume":"8","author":"CW Woods","year":"2002","unstructured":"Woods CW, Karpati AM, Grein T, McCarthy N, Gaturuku P, Muchiri E, et al. An outbreak of Rift Valley fever in Northeastern Kenya, 1997\u201398. Emerg Infect Dis. 2002;8:138\u201344.","journal-title":"Emerg Infect Dis"},{"key":"392_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1086\/345671","volume":"36","author":"M Al-Hazmi","year":"2003","unstructured":"Al-Hazmi M, Ayoola EA, Abdurahman M, Banzal S, Ashraf J, El-Bushra A, et al. Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans. Clin Infect Dis. 2003;36:245\u201352.","journal-title":"Clin Infect Dis"},{"key":"392_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4269\/ajtmh.2010.09-0318","volume":"83","author":"M Mohamed","year":"2010","unstructured":"Mohamed M, Mosha F, Mghamba J, Zaki SR, Shieh WJ, Paweska J, et al. Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007. Am J Trop Med Hyg. 2010;83:22\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"392_CR7","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","volume":"75","author":"M Bouloy","year":"2001","unstructured":"Bouloy M, Janzen C, Vialat P, Khun H, Pavlovic J, Huerre M, et al. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol. 2001;75:1371\u20137.","journal-title":"J Virol"},{"key":"392_CR8","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","volume":"80","author":"T Ikegami","year":"2006","unstructured":"Ikegami T, Won S, Peters CJ, Makino S. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol. 2006;80:2933\u201340.","journal-title":"J Virol"},{"key":"392_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S1097-2765(04)00092-9","volume":"13","author":"A Dasgupta","year":"2004","unstructured":"Dasgupta A. Targeting TFIIH to inhibit host cell transcription by Rift Valley Fever Virus. Mol Cell. 2004;13:456\u20138.","journal-title":"Mol Cell"},{"key":"392_CR10","first-page":"e13","volume":"4","author":"N May Le","year":"2008","unstructured":"Le May N, Mansuroglu Z, L\u00e9ger P, Josse T, Blot G, Billecocq A, et al. A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoSPathog. 2008;4:e13.","journal-title":"PLoSPathog"},{"key":"392_CR11","doi-asserted-by":"publisher","first-page":"9798","DOI":"10.1128\/JVI.78.18.9798-9806.2004","volume":"78","author":"A Billecocq","year":"2004","unstructured":"Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, Bouloy M, et al. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol. 2004;78:9798\u2013806.","journal-title":"J Virol"},{"key":"392_CR12","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1128\/JVI.02148-08","volume":"83","author":"M Habjan","year":"2009","unstructured":"Habjan M, Pichlmair A, Elliott RM, Overby AK, Glatter T, Gstaiger M, et al. NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol. 2009;83:4365\u201375.","journal-title":"J Virol"},{"issue":"Suppl 1","key":"392_CR13","doi-asserted-by":"publisher","first-page":"E75","DOI":"10.1111\/j.1749-6632.2009.05054.x","volume":"1171","author":"T Ikegami","year":"2009","unstructured":"Ikegami T, Narayanan K, Won S, Kamitani W, Peters CJ, Makino S. Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. Ann N Y AcadSci. 2009;1171 Suppl 1:E75\u201385.","journal-title":"Ann N Y AcadSci"},{"key":"392_CR14","first-page":"8","volume":"4","author":"M Bouloy","year":"2010","unstructured":"Bouloy M, Weber F. Molecular biology of rift valley Fever virus. Open Virol J. 2010;4:8\u201314.","journal-title":"Open Virol J"},{"key":"392_CR15","doi-asserted-by":"publisher","first-page":"13335","DOI":"10.1128\/JVI.01238-07","volume":"81","author":"S Won","year":"2007","unstructured":"Won S, Ikegami T, Peters CJ, Makino S. NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J Virol. 2007;81:13335\u201345.","journal-title":"J Virol"},{"issue":"4","key":"392_CR16","doi-asserted-by":"publisher","first-page":"e9986","DOI":"10.1371\/journal.pone.0009986","volume":"5","author":"JC Morril","year":"2010","unstructured":"Morril JC, Ikegami T, Yoshikawa-Iwata N, Lokugamage N, Won S, Terasaki K, et al. Rapid accumulation of virulent Rift Valley fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the M RNA. PLoS One. 2010;5(4):e9986.","journal-title":"PLoS One"},{"key":"392_CR17","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/1743-422X-8-532","volume":"8","author":"SA Kamal","year":"2011","unstructured":"Kamal SA. Observations on Rift Valley fever virus and vaccines in Egypt. Virol J. 2011;8:532.","journal-title":"Virol J"},{"key":"392_CR18","doi-asserted-by":"publisher","first-page":"6534","DOI":"10.1016\/j.vaccine.2012.08.052","volume":"30","author":"N Lagerqvist","year":"2012","unstructured":"Lagerqvist N, Moiane B, Bucht G, Fafetine J, Paweska JT, Lundkvist A, et al. Stability of a formalin-inactivated Rift Valley Fever vaccine: evaluation of a vaccination campaign for cattle in Mozambique. Vaccine. 2012;30:6534\u201340.","journal-title":"Vaccine"},{"key":"392_CR19","doi-asserted-by":"publisher","first-page":"12901","DOI":"10.1128\/JVI.06046-11","volume":"85","author":"BH Bird","year":"2011","unstructured":"Bird BH, Maartens LH, Campbell S, Erasmus BJ, Erickson BR, Dodd KA, et al. Rift Valley fever virus lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep. J Virol. 2011;85:12901\u20139.","journal-title":"J Virol"},{"key":"392_CR20","doi-asserted-by":"publisher","first-page":"10310","DOI":"10.1128\/JVI.05252-11","volume":"85","author":"B Brennan","year":"2011","unstructured":"Brennan B, Welch SR, McLees A, Elliott RM. Creation of a recombinant Rift Valley fever virus with a two-segmented genome. J Virol. 2011;85:10310\u20138.","journal-title":"J Virol"},{"key":"392_CR21","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.1128\/JVI.07104-11","volume":"86","author":"KA Dodd","year":"2012","unstructured":"Dodd KA, Bird BH, Metcalfe MG, Nichol ST, Albarino CG. Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge. J Virol. 2012;86:4204\u201312.","journal-title":"J Virol"},{"key":"392_CR22","doi-asserted-by":"publisher","first-page":"12622","DOI":"10.1128\/JVI.00841-11","volume":"85","author":"J Kortekaas","year":"2011","unstructured":"Kortekaas J, Oreshkova N, Cobos-Jim\u00e9ez V, Vloet RPM, Potgieter CA, Moormann RJM. Creation of a nonspreading Rift Valley fever virus. J Virol. 2011;85:12622\u201330.","journal-title":"J Virol"},{"key":"392_CR23","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1586\/erv.12.106","volume":"11","author":"O Lihoradowa","year":"2012","unstructured":"Lihoradowa O, Ikegami T. Modifying the NSs gene to imrove live-attenuated vaccine for Rift Valley fever. Exp Rev Vac. 2012;11:1283\u20135.","journal-title":"Exp Rev Vac"},{"key":"392_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3851\/IMP2073","volume":"17","author":"T Scott","year":"2012","unstructured":"Scott T, Paweska JT, Arbuthnot P, Weinberg MS. Pathogenic effects of Rift Vally fever virus NSs gene are alleviated in cultured cells by expressed antiviral short hairpin RNAs. Antivir Ther. 2012;17:643\u201356.","journal-title":"Antivir Ther"},{"key":"392_CR25","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3390\/v6031410","volume":"6","author":"BB Gowen","year":"2014","unstructured":"Gowen BB, Ennis J, Bailey KW, Vest Z, Scharton D, Sefing EJ, et al. Single-dose intranasal treatment with DEF201 (Adenovirus vectored consensus interferon) prevents lethal disease due to Rift Valley fever virus challenge. Viruses. 2014;6:1410\u201323.","journal-title":"Viruses"},{"key":"392_CR26","doi-asserted-by":"publisher","first-page":"33198","DOI":"10.1074\/jbc.M112.356535","volume":"40","author":"A Narayanan","year":"2012","unstructured":"Narayanan A, Kehn-Hall K, Senina S, Hill L, van Duyne R, Guendel I, et al. Curcumin inhibits Rift Valley fever replication in human cells. J Biol Chem. 2012;40:33198\u2013214.","journal-title":"J Biol Chem"},{"issue":"4","key":"392_CR27","doi-asserted-by":"publisher","first-page":"e2790","DOI":"10.1371\/journal.pntd.0002790","volume":"8","author":"AL Caroline","year":"2014","unstructured":"Caroline AL, Powel DS, Bethel LM, Oury TD, Reed DS, Hartman AL. Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalation Rift Valley fever. PLoS Negl Trop Dis. 2014;8(4):e2790.","journal-title":"PLoS Negl Trop Dis"},{"key":"392_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.antiviral.2014.01.016","volume":"104","author":"D Scharton","year":"2014","unstructured":"Scharton D, Bailey KW, Vest Z, Westover JB, Kumaki Y, Van Wettere A, et al. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment. Antiviral Res. 2014;104:84\u201392.","journal-title":"Antiviral Res"},{"key":"392_CR29","doi-asserted-by":"publisher","first-page":"e2507","DOI":"10.1371\/journal.pone.0025027","volume":"6","author":"P Jansen van Vuren","year":"2011","unstructured":"Jansen van Vuren P, Tiemessen CT, Paweska JT. Anti-nucleocapsid immune responses counteract pathogenic effects if Rift Valley fever virus infection in mice. PLoS ONE. 2011;6:e2507.","journal-title":"PLoS ONE"},{"key":"392_CR30","doi-asserted-by":"publisher","first-page":"e1529","DOI":"10.1371\/journal.pntd.0001529","volume":"6","author":"KK Gray","year":"2012","unstructured":"Gray KK, Worthu MN, Juelich TL, Agar SL, Pousssard A, Ragland D, et al. Chemotactic and inflamatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse. PLoS Negl TropDis. 2012;6:e1529.","journal-title":"PLoS Negl TropDis"},{"issue":"1","key":"392_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.virol.2011.09.023","volume":"422","author":"AK McElroy","year":"2012","unstructured":"McElroy AK, Nichol ST. Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. Virology. 2012;422(1):6\u201312.","journal-title":"Virology"},{"issue":"4","key":"392_CR32","first-page":"1166","volume":"47","author":"MK Njenga","year":"2009","unstructured":"Njenga MK, Paweska JT, Wanjala R, Rao CY, Weiner M, Omballa V, et al. Using a field quantitative real-time PCR test to rapidly identify highly viremic Rift Valley fever cases. J ClinMicrob. 2009;47(4):1166\u201371.","journal-title":"J ClinMicrob"},{"issue":"2","key":"392_CR33","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1177\/147323001204000227","volume":"40","author":"PZ Wang","year":"2012","unstructured":"Wang PZ, Li ZD, Yu HT, Zhang Y, Wang W, Jiang W, et al. Elevated serum concentrations of inflammatory cytokines and chemokines in patients with haemorrhagic fever with renal syndrome. J Int Med Res. 2012;40(2):648\u201356.","journal-title":"J Int Med Res"},{"issue":"4","key":"392_CR34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/cid\/cir804","volume":"54","author":"YZ Zhang","year":"2012","unstructured":"Zhang YZ, He YW, Dai YA, Xiong Y, Zheng H, Zhou DJ, et al. Hemorrhagic fever caused by a novel bunyavirus in china: pathogenesis and correlates of fatal outcome. Clin Infect Dis. 2012;54(4):527\u201333.","journal-title":"Clin Infect Dis"},{"key":"392_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2172-12-65","volume":"12","author":"M Sadeghi","year":"2011","unstructured":"Sadeghi M, Eckerle I, Daniel V, Burkhardt U, Opelz G, Schnitzler P. Cytokine expression during early and late phase of acute Puumala hantavirus infection. BMC Immunol. 2011;12:65.","journal-title":"BMC Immunol"},{"issue":"Suppl1","key":"392_CR36","doi-asserted-by":"publisher","first-page":"S188","DOI":"10.1086\/514283","volume":"179","author":"F Villinger","year":"1999","unstructured":"Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, Sundstrom JB, et al. Markedly elevated levels of Interferon (IFN)-\u03b3, IFN-\u03b1, Intlerleukin (IL)-2, IL-10, and tumor necrosis factor-\u03b1 associated with fatal Ebola virus infection. J Infect Dis. 1999;179(Suppl1):S188\u201391.","journal-title":"J Infect Dis"},{"issue":"Suppl2","key":"392_CR37","doi-asserted-by":"publisher","first-page":"S357","DOI":"10.1086\/520611","volume":"196","author":"KL Hutchinson","year":"2007","unstructured":"Hutchinson KL, Rollin PE. Cytokine and chemokine expression in humans infected with Sudan Ebola virus. J Infect Dis. 2007;196(Suppl2):S357\u201363.","journal-title":"J Infect Dis"},{"issue":"10","key":"392_CR38","doi-asserted-by":"publisher","first-page":"e837","DOI":"10.1371\/journal.pntd.0000837","volume":"4","author":"N Wauquier","year":"2010","unstructured":"Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM. Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis. 2010;4(10):e837.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"392_CR39","doi-asserted-by":"publisher","first-page":"e21381","DOI":"10.1371\/journal.pone.0021381","volume":"6","author":"HW Zimmermann","year":"2011","unstructured":"Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, Trautwein C, et al. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One. 2011;6(6):e21381.","journal-title":"PLoS One"},{"issue":"1","key":"392_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaut.2009.08.003","volume":"34","author":"C Drucker","year":"2010","unstructured":"Drucker C, Gewiese J, Malchow S, Scheller J, Rose-John S. Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration. J Autoimmun. 2010;34(1):29\u201337.","journal-title":"J Autoimmun"},{"key":"392_CR41","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1469-0691.2009.02996.x","volume":"16","author":"A Papa","year":"2010","unstructured":"Papa A, Dalla V, Papadimitriou E, Kartalis GN, Antoniadis A. Emergence of Crimean-Congo haemorrhagic fever in Greece. ClinMicrobiol Infect. 2010;16:843\u20137.","journal-title":"ClinMicrobiol Infect"},{"key":"392_CR42","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/00365540310015935","volume":"35","author":"JM Cavaillon","year":"2003","unstructured":"Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D. Cytokine cascade in sepsis. Scand J Infect Dis. 2003;35:535\u201344.","journal-title":"Scand J Infect Dis"},{"key":"392_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1086\/315680","volume":"182","author":"ED Carrol","year":"2000","unstructured":"Carrol ED, Thomson APJ, Mobbs KJ, Hart CA. The role of RANTES in meningococcal disease. J Infect Dis. 2000;182:363\u20136.","journal-title":"J Infect Dis"},{"key":"392_CR44","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1086\/506623","volume":"194","author":"CC John","year":"2006","unstructured":"John CC, Opika-Opoka R, Byarugaba J, Idro R, Boivin MJ. Low levels of RANTES are associated with mortality in children with cerebral malaria. J Infect Dis. 2006;194:837\u201345.","journal-title":"J Infect Dis"},{"issue":"1","key":"392_CR45","doi-asserted-by":"publisher","first-page":"e4261","DOI":"10.1371\/journal.pone.0004261","volume":"4","author":"LFP Ng","year":"2009","unstructured":"Ng LFP, Chow A, Sun Y-J, Kwek DJC, Lim P-L, Dimatatac F, et al. IL-1b, IL-6, and RANTES as Biomarkers of Chikungunya Severity. PLoS ONE. 2009;4(1):e4261.","journal-title":"PLoS ONE"},{"issue":"10","key":"392_CR46","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3201\/eid2010.140430","volume":"20","author":"AK McElroy","year":"2014","unstructured":"McElroy AK, Erickson BR, Flietstra TD, Rollin PE, Nichol ST, Towner JS, et al. Biomarker Correlates of Survival in Pediatric Patients with Ebola Virus Disease. Emerg Infect Dis. 2014;20(10):1683\u201390.","journal-title":"Emerg Infect Dis"},{"key":"392_CR47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1096\/fsb2fasebj.12.1.79","volume":"12","author":"PA Holme","year":"1998","unstructured":"Holme PA, Muller F, Solum NO, Brosstad F, Fro\u00fdland SS, Aukrust P. Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection. FASEB J. 1998;12:79\u201390.","journal-title":"FASEB J"},{"issue":"6","key":"392_CR48","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1161\/01.RES.0000160077.17427.57","volume":"96","author":"C Weber","year":"2005","unstructured":"Weber C. Platelets and chemokines in atherosclerosis: partners in crime. Circ Res. 2005;96(6):612\u20136.","journal-title":"Circ Res"},{"key":"392_CR49","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1084\/jem.176.2.587","volume":"176","author":"Y Kameyoshi","year":"1992","unstructured":"Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder J-M. Cytokine RANTES released by thrombin stimulated platelets is a potent attractant for human eosinophils. J Exp Med. 1992;176:587\u201392.","journal-title":"J Exp Med"},{"key":"392_CR50","doi-asserted-by":"publisher","unstructured":"Yu C, Zhang S, Wang Y, Zhang S, Luo L, Thorlacius H: Platelet-Derived CCL5 Regulates CXC Chemokine Formation and Neutrophil Recruitment in Acute Experimental Colitis. J Cell Physiol 2015, doi:\n                    10.1002\/jcp.25081","DOI":"10.1002\/jcp.25081"},{"issue":"12","key":"392_CR51","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3201\/eid1912.121527","volume":"19","author":"BN Archer","year":"2013","unstructured":"Archer BN, Thomas J, Weyer J, Cengimbo A, Landoh DE, Jacobs C, et al. Epidemiologic investigations into outbreaks of rift valley Fever in humans, South Africa, 2008\u20132011. Emerg Infect Dis. 2013;19(12):1918\u201325.","journal-title":"Emerg Infect Dis"},{"key":"392_CR52","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2174\/1875035401003010114","volume":"3","author":"P Jansen Van Vuren","year":"2010","unstructured":"Jansen Van Vuren P, Tiemessen CT, Paweska JT. Evaluation of a recombinant Rift Valley fever virus subunit nucleocapsid protein as an immunogen in mice and sheep. Open Vacc J. 2010;3:114\u201326.","journal-title":"Open Vacc J"},{"key":"392_CR53","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF01863914","volume":"162","author":"G K\u00e4rber","year":"1931","unstructured":"K\u00e4rber G. Beitragzurkollectiven Behandlung pharmakologischer Reihensversuche. Arch Exp Path Pharma. 1931;162:480\u20133.","journal-title":"Arch Exp Path Pharma"},{"key":"392_CR54","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1128\/JVI.02095-06","volume":"81","author":"BH Bird","year":"2007","unstructured":"Bird BH, Khristova ML, Rollin PE, Ksiazek TG, Nichol ST. Complete genome analysis of 33 ecologically and biologically diverse Rift Valley Fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry. J Virol. 2007;81:2805\u201316.","journal-title":"J Virol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0392-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-015-0392-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0392-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0392-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T12:34:44Z","timestamp":1583152484000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-015-0392-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,6]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["392"],"URL":"https:\/\/doi.org\/10.1186\/s12985-015-0392-3","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,6]]},"assertion":[{"value":"22 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"159"}}